Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 2022 Apr;63(4):380-388. doi: 10.3349/ymj.2022.63.4.380.
Perioperative fluid management in kidney transplant recipients is crucial to supporting the fluid, acid-base, and electrolyte balance required for graft perfusion. However, the choice of intraoperative crystalloids in kidney transplantation remains controversial. We conducted a single-center retrospective cohort study to evaluate the impact of intraoperative fluids on acid-base and electrolyte balance and graft outcomes.
We included 282 living donor kidney transplant recipients from January 2010 to December 2017. Patients were classified into two groups based on the type of intraoperative crystalloids used (157 patients in the half saline group and 125 patients in the balanced crystalloid solutions group, Plasma-lyte).
Compared with the half saline group, the Plasma-lyte group showed less metabolic acidosis and hyponatremia during surgery. Hyperkalemia incidence was not significantly different between the two groups. Changes in postoperative graft function assessed by blood urea nitrogen and creatinine were significantly different between the two groups. Patients in the Plasma-lyte group exhibited consistently higher glomerular filtration rates than those in the half saline group at 1 month and 1 year after transplantation after adjusting for demographic differences.
Intraoperative Plasma-lyte can lead to more favorable results in terms of acid-base balance during kidney transplantation. Patients who received Plasma-lyte showed superior postoperative graft function at 1 month and 1 year after transplantation. Further studies are needed to evaluate the superiority of intraoperative Plasma-lyte over other types of crystalloids in relation to graft outcomes.
肾移植受者围手术期液体管理对于支持移植肾灌注所需的液体、酸碱和电解质平衡至关重要。然而,肾移植术中晶体液的选择仍存在争议。我们进行了一项单中心回顾性队列研究,以评估术中液体对酸碱和电解质平衡以及移植物结局的影响。
我们纳入了 2010 年 1 月至 2017 年 12 月期间 282 例活体供肾移植受者。根据术中使用的晶体液类型(半盐水组 157 例,平衡晶体液溶液组[Plasma-lyte]125 例)将患者分为两组。
与半盐水组相比,Plasma-lyte 组在手术期间发生代谢性酸中毒和低钠血症的情况较少。两组间高钾血症的发生率无显著差异。两组间术后通过血尿素氮和肌酐评估的移植物功能变化存在显著差异。调整了人口统计学差异后,移植后 1 个月和 1 年,Plasma-lyte 组的肾小球滤过率始终高于半盐水组。
术中使用 Plasma-lyte 可在肾移植过程中获得更有利的酸碱平衡结果。接受 Plasma-lyte 的患者在移植后 1 个月和 1 年的术后移植物功能更好。需要进一步研究来评估术中使用 Plasma-lyte 相对于其他类型晶体液在移植物结局方面的优越性。